Grants Awarded



Click on any project title for a more detailed description of the project. For more information about any of these awards (e.g., PI contact information or associated publications), please use the corresponding project number to search for information at the NIH Reporter website. Consistent with NIH policy, abstracts are not available for projects receiving their first award within the past year, so descriptions provided below are from the NCI program director.

New awards will be posted as they are issued.

Year Award Type Project # RFA # PI/Project Leader Institution Title Statussort descending
2020 R21 RFA-CA-19-019 TEWARI, MUNEESH UNIVERSITY OF MICHIGAN AT ANN ARBOR Highly Specific, Amplification-free, Single-molecule Counting Of Rare Methylated Dna Cancer Biomarkers Active
2019 R33 RFA-CA-18-005 LEI, YUGUO UNIVERSITY OF NEBRASKA LINCOLN A Single Conical Tube Device for Precision CAR-T Cells Manufacturing Active
2019 R43 PAR-18-303 WARREN, CHRISTOPHER L PROTEOVISTA, LLC Development of the High Throughput APT-SNAP Platform for Rapid Identification ofNuclease-Resistant RNA Aptamers against p53 Missense Mutations Active
2018 R21 RFA-CA-17-010 ENGLER, ADAM JEFFREY UNIVERSITY OF CALIFORNIA, SAN DIEGO Developing Adhesome Technology as a Physical Marker of Highly Metastatic Cells Active
2020 R33 RFA-CA-19-020 WANG, SIYUAN YALE UNIVERSITY Multiplexed Imaging Of Chromatin Folding And Rna Profiles In Cancer Active
2020 R21 RFA-CA-19-019 HUR, SOOJUNG CLAIRE JOHNS HOPKINS UNIVERSITY Development of a microfluidic primary cell editing platform (pCEP) for personal gene therapy Active
2017 R21 RFA-CA-16-001 KARGINOV, ANDREI V UNIVERSITY OF ILLINOIS AT CHICAGO Engineered regulation of tyrosine phosphatase activity in living cells Active
2020 R43 PAR-18-303 WARREN, CHRISTOPHER L PROTEOVISTA, LLC Development Of The High Throughput Apt-snap Platform For Rapid Identification Ofnuclease-resistant Rna Aptamers Against P53 Missense Mutations Active
2020 R21 RFA-CA-19-019 REVZIN, ALEXANDER MAYO CLINIC ROCHESTER A microfluidic cell culture platform for personalizing pancreatic cancer therapies Active
1999 R44 PAR-98-066 LIFSHITZ, NADIA BIOPHOTONICS CORPORATION HIGH THROUGHPUT, HIGH RESOLUTION DNA SEQUENCING Complete
2002 R21 PAR-01-106 SHIH, IE-MING JOHNS HOPKINS UNIVERSITY DEVELOPMENT OF DIGITAL SNP ANALYSIS IN CANCER DETECTION Complete
2005 R21 RFA-CA-05-002 PUN, SUZIE H UNIVERSITY OF WASHINGTON NANOPARTICLES FOR EFFICIENT DELIVERY TO SOLID TUMORS Complete
2008 R21 RFA-CA-07-033 CAMP, ROBERT L YALE UNIVERSITY NOVEL METHODS TO LOCALIZE PROTEIN-PROTEIN INTERACTIONS IN FIXED CELLS AND TISSUES Complete
2011 R21 RFA-CA-10-003 ALEXANDRAKIS, GEORGIOS UNIVERSITY OF TEXAS ARLINGTON SCANNING CORRELATION MICROSCOPY METHODS FOR QUANTIFYING DNA REPAIR KINETICS Complete
2015 R21 RFA-CA-14-003 BHATNAGAR, PARIJAT BAYLOR COLLEGE OF MEDICINE CELLULAR BIOFACTORIES FOR THERAPEUTIC PROTEIN SYNTHESIS IN TUMOR MICROENVIRONMENT Complete
1999 R21 PAR-98-067 MAKRIGIORGOS, G. MIKE DANA-FARBER CANCER INSTITUTE TECHNOLOGY FOR MUTATION ANALYSIS OF CANCER Complete
2001 R33 PAR-99-102 CHAIT, BRIAN T ROCKEFELLER UNIVERSITY COMPREHENSIVE MAP OF CELLULAR PROTEIN INTERACTIONS Complete
2004 R21 PAR-01-104 REN, BING LUDWIG INSTITUTE FOR CANCER RESEARCH TRANSCRIPTION FACTOR TARGET MAPPING IN MAMMALIAN GENOME Complete
2007 R21 RFA-CA-07-015 SOPER, STEVEN ALLAN LOUISIANA STATE UNIV A&M COL BATON ROUGE GENOTYPING MOLECULAR SIGNATURES OF CRC USING POLYMER MICROCHIP-CE AND FSCE Complete
2010 R21 RFA-CA-09-006 SOOD, ANUP GENERAL ELECTRIC GLOBAL RESEARCH CTR RELEASABLE ANTIBODIES FOR MULTIPLEXED ANALYSIS OF CANCER BIOMARKERS Complete
2014 R21 RFA-CA-13-001 PETUKHOV, PAVEL A UNIVERSITY OF ILLINOIS AT CHICAGO PHOTOREACTIVE HISTONE DEACETYLASE PROBES FOR CHROMATIN IMMUNOPRECIPITATION IN CAN Complete
2001 R21 PAR-99-100 CONDEELIS, JOHN S YESHIVA UNIVERSITY NOVEL IMAGING METHODS FOR GENE DISCOVERY IN CANCER Complete
2003 R21 PAR-01-104 MAJUMDAR, ARUNAVA UNIVERSITY OF CALIFORNIA BERKELEY NANOCAPILLARY ELECTROPHORESIS FOR PROFILING CANCER Complete
2006 R33 RFA-CA-06-003 ELENITOBA-JOHNSON, KOJO SEYS JOHN UNIVERSITY OF MICHIGAN AT ANN ARBOR QUANTITATIVE PROTEOMIC ANALYSIS OF LYMPHOMA TRANSFORMATION Complete
2009 R21 RFA-CA-08-007 GODLEY, LUCY ANN UNIVERSITY OF CHICAGO A CHEMICAL CROSSLINKING STRATEGY TO DETERMINE DNA METHYLATING PROTEIN COMPLEXES Complete
2013 R21 RFA-CA-12-002 HARISMENDY, OLIVIER UNIVERSITY OF CALIFORNIA SAN DIEGO IN VIVO DETECTION AND GENOME-WIDE LOCATION ANALYSIS OF DNA-ADDUCTS Complete
2000 R21 PAR-98-066 HAMPDEN-SMITH, MARK J SUPERIOR MICROPOWDERS, LLC UNIQUE, SMALL PARTICLE PHOSPHOR POWDERS FOR IMUNOASSAYS Complete
2002 R33 PAR-99-100 SUTHERLAND, JOHN CLARK BROOKHAVEN SCIENCE ASSOC-BROOKHAVEN LAB DNA DAMAGE QUANTITATION BY SINGLE MOLECULE LASER SIZING Complete
2005 R43 RFA-CA-05-006 MOEN, PHILLIP T ONE CELL SYSTEMS, INC DETECTING INTEGRATED HPV DNA IN IMMUNOCOMPROMISED WOMEN Complete
2008 R43 RFA-CA-07-039 TYRRELL, STEVEN PATRICK CONTROLLED PROCESS TECHNOLOGIES, LLC A RAPID SOLUTION-PHASE IMMUNOASSAY FOR PROTEOMICS Complete
2011 R33 RFA-CA-10-004 TSENG, HSIAN-RONG UNIVERSITY OF CALIFORNIA LOS ANGELES ADVANCED DEVELOPMENT OF AN INTEGRATED CTC ENRICHMENT TECHNOLOGY Complete
2015 R33 RFA-CA-14-006 BOMSZTYK, KAROL UNIVERSITY OF WASHINGTON NEXT GENERATION TECHNOLOGY TO DETECT EPIGENETIC ALTERATIONS IN HUMAN TISSUES Complete
1999 R44 PAR-98-066 ANDERSON, N LEIGH LARGE SCALE BIOLOGY CORPORATION PROTEOMIC TECHNOLOGIES FOR CANCER RESEARCH Complete
2002 R21 PAR-01-106 GARCIA-BLANCO, MARIANO A. DUKE UNIVERSITY IMAGING ALTERNATIVE SPLICING DURING TUMOR PROGRESSION Complete
2005 R21 RFA-CA-05-002 ZHANG, HUI INSTITUTE FOR SYSTEMS BIOLOGY PROFILE SERUM PROTEINS BY GLYCOPEPTIDE CAPTURE AND LC-MS Complete
2008 R21 RFA-CA-07-033 MACBEATH, GAVIN HARVARD UNIVERSITY QUANTITATIVE, MULTIPLEXED AND HIGH-THROUGHPUT: MACROARRAYS OF LYSATE MICROARRAYS Complete
2011 R21 RFA-CA-10-003 YAO, XUDONG UNIVERSITY OF CONNECTICUT STORRS ULTRATHROUGHPUT MULTIPLE REACTION MONITORING MASS SPECTROMETRY FOR LARGE-SCALE CA Complete
2015 R21 RFA-CA-14-003 HALL, ADAM ROGER WAKE FOREST UNIVERSITY HEALTH SCIENCES MOLECULAR DETECTION OF DNA HYDROXYMETHYLATION FOR CANCER SCREENING Complete
1999 R21 PAR-98-067 WIND, ROBERT A BATTELLE PACIFIC NORTHWEST LABORATORIES INTEGRATED OPTICAL/MAGNETIC RESONANCE MICROSCOPY Complete
2001 R33 PAR-99-102 GRIFFITH, JEFFREY K UNIVERSITY OF NEW MEXICO PROGNOSTIC VALUE OF TELOMERE DNA IN PROSTATE BIOPSY Complete
2004 R21 PAR-01-104 WANG, YUE VIRGINIA POLYTECHNIC INST AND ST UNIV COMPREHENSIVE ANALYSIS OF MICROARRAY GENE EXPRESSION Complete
2007 R21 RFA-CA-07-015 ANDREEV, OLEG A UNIVERSITY OF RHODE ISLAND NEW TECHNOLOGY FOR SELECTIVE DELIVERY OF PNAS IN CANCER CELLS IN VITRO AND IN VIV Complete
2010 R21 RFA-CA-09-006 RICHARDSON, ADAM DAVID SANFORD-BURNHAM MEDICAL RESEARCH INSTIT FUNCTIONAL METABOLOMICS AND METABOLIC FLUX ANALYSIS IN CANCER Complete
2014 R21 RFA-CA-13-001 CIMA, MICHAEL J MASSACHUSETTS INSTITUTE OF TECHNOLOGY IMPLANTABLE DEVICE FOR HIGH-THROUGHPUT IN VIVO DRUG SENSITIVITY TESTING Complete
2017 R21 RFA-CA-16-001 WONG, IAN Y BROWN UNIVERSITY High Content Screening of Multicellular Invasion with 3D Traction Force Microscopy Complete
2001 R21 PAR-99-100 FRESCO, JACQUES R PRINCETON UNIVERSITY FLUORESCENT TISH PROBES FOR CANCER REVELANT SEQUENCES Complete
2003 R21 PAR-01-104 KRON, STEPHEN J. UNIVERSITY OF CHICAGO BCR-ABL KINASE ASSAYS FOR STI571 SENSITIVITY OF RESPONSE Complete
2006 R33 RFA-CA-06-004 CHU, WEI-SING AMERICAN REGISTRY OF PATHOLOGY, INC. ULTRASOUND-ACCELERATED TISSUE FORMALIN FIXATION AND PARAFFIN EMBEDDING Complete
2009 R21 RFA-CA-08-007 SHEN, LANLAN UNIVERSITY OF TX MD ANDERSON CAN CTR MASSIVELY PARALLEL SEQUENCING TECHNOLOGY FOR CANCER EPIGENOME. Complete
2013 R21 RFA-CA-12-002 QUINN, THOMAS P. UNIVERSITY OF MISSOURI-COLUMBIA IN VIVO METAL-FREE CYCLOADDITION CHEMISTRY DRIVEN PRETARGETED CANCER RADIOTHERAPY Complete

Pages